EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
6.1.1.1 | 3-phenyl-4-(phenylamino)furan-2(5H)-one | - |
Staphylococcus aureus | |
6.1.1.1 | additional information | synthesis and evaluation of new tyrosyl-tRNA synthetase inhibitors as antibacterial agents based on a N2-(arylacetyl)glycinanilide scaffold, molecular docking study, antimicrobial activity, overview | Staphylococcus aureus | |
6.1.1.1 | N-(2-chlorophenyl)-N2-(phenylacetyl)glycinamide | - |
Staphylococcus aureus | |
6.1.1.1 | N-(3,5-dichlorophenyl)-N2-(phenylacetyl)glycinamide | - |
Staphylococcus aureus | |
6.1.1.1 | N-(3,5-difluorophenyl)-N2-(phenylacetyl)glycinamide | - |
Staphylococcus aureus | |
6.1.1.1 | N-(3,5-dimethoxyphenyl)-N2-(phenylacetyl)glycinamide | - |
Staphylococcus aureus | |
6.1.1.1 | N-(3-chlorophenyl)-N2-(phenylacetyl)glycinamide | - |
Staphylococcus aureus | |
6.1.1.1 | N-(3-nitrophenyl)-N2-(phenylacetyl)glycinamide | - |
Staphylococcus aureus | |
6.1.1.1 | N-(4-bromophenyl)-N2-(phenylacetyl)glycinamide | - |
Staphylococcus aureus | |
6.1.1.1 | N-(4-bromophenyl)-N2-[(2-chlorophenyl)acetyl]glycinamide | - |
Staphylococcus aureus | |
6.1.1.1 | N-(4-bromophenyl)-N2-[(3-bromophenyl)acetyl]glycinamide | - |
Staphylococcus aureus | |
6.1.1.1 | N-(4-bromophenyl)-N2-[(3-chlorophenyl)acetyl]glycinamide | - |
Staphylococcus aureus | |
6.1.1.1 | N-(4-chlorophenyl)-N2-(phenylacetyl)glycinamide | - |
Staphylococcus aureus | |
6.1.1.1 | N-(4-methoxyphenyl)-N2-(phenylacetyl)glycinamide | - |
Staphylococcus aureus | |
6.1.1.1 | N-(4-nitrophenyl)-N2-(phenylacetyl)glycinamide | - |
Staphylococcus aureus | |
6.1.1.1 | N-phenyl-N2-(phenylacetyl)glycinamide | - |
Staphylococcus aureus | |
6.1.1.1 | N2-[(2-chlorophenyl)acetyl]-N-(4-methoxyphenyl)glycinamide | - |
Staphylococcus aureus | |
6.1.1.1 | N2-[(2-chlorophenyl)acetyl]-N-(4-nitrophenyl)glycinamide | - |
Staphylococcus aureus | |
6.1.1.1 | N2-[(2-hydroxyphenyl)acetyl]-N-(4-methoxyphenyl)glycinamide | - |
Staphylococcus aureus | |
6.1.1.1 | N2-[(3,4-dimethoxyphenyl)acetyl]-N-(4-methoxyphenyl)glycinamide | - |
Staphylococcus aureus | |
6.1.1.1 | N2-[(3,4-dimethoxyphenyl)acetyl]-N-(4-nitrophenyl)glycinamide | - |
Staphylococcus aureus | |
6.1.1.1 | N2-[(3-chlorophenyl)acetyl]-N-(4-methoxyphenyl)glycinamide | - |
Staphylococcus aureus | |
6.1.1.1 | N2-[(3-chlorophenyl)acetyl]-N-(4-methylphenyl)glycinamide | - |
Staphylococcus aureus | |
6.1.1.1 | N2-[(3-chlorophenyl)acetyl]-N-(4-nitrophenyl)glycinamide | - |
Staphylococcus aureus | |
6.1.1.1 | N2-[(3-fluorophenyl)acetyl]-N-(4-methoxyphenyl)glycinamide | - |
Staphylococcus aureus | |
6.1.1.1 | N2-[(3-fluorophenyl)acetyl]-N-(4-nitrophenyl)glycinamide | - |
Staphylococcus aureus | |
6.1.1.1 | N2-[(3-hydroxyphenyl)acetyl]-N-(4-methoxyphenyl)glycinamide | - |
Staphylococcus aureus | |
6.1.1.1 | N2-[(3-hydroxyphenyl)acetyl]-N-(4-nitrophenyl)glycinamide | - |
Staphylococcus aureus | |
6.1.1.1 | N2-[(4-chlorophenyl)acetyl]-N-(3,5-dichlorophenyl)glycinamide | - |
Staphylococcus aureus | |
6.1.1.1 | N2-[(4-chlorophenyl)acetyl]-N-(4-methoxyphenyl)glycinamide | - |
Staphylococcus aureus | |
6.1.1.1 | N2-[(4-fluorophenyl)acetyl]-N-(4-methoxyphenyl)glycinamide | - |
Staphylococcus aureus | |
6.1.1.1 | N2-[(4-fluorophenyl)acetyl]-N-(4-nitrophenyl)glycinamide | - |
Staphylococcus aureus | |
6.1.1.1 | N2-[(4-hydroxyphenyl)acetyl]-N-(4-methoxyphenyl)glycinamide | - |
Staphylococcus aureus | |
6.1.1.1 | N2-[(4-hydroxyphenyl)acetyl]-N-(4-nitrophenyl)glycinamide | - |
Staphylococcus aureus | |
6.1.1.1 | N2-[(4-methylphenyl)acetyl]-N-(4-nitrophenyl)glycinamide | - |
Staphylococcus aureus |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
6.1.1.1 | Staphylococcus aureus | - |
- |
- |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
6.1.1.1 | Tyrosyl-tRNA synthetase | - |
Staphylococcus aureus |